| 摘要 |
Disclosed are therapeutic compounds having the formula: (R)j - (core moiety), including resolved enantiomers, diastereomers, hydrates, salts, solvates and mixtures thereof. j is an integer from one to three, the core moiety is either non-cyclic or comprises at least one five- to seven-membered ring structure, R may be selected from the group consisting of hydrogen, halogen, hydroxyl, amino, substituted or unsubstituted benzyl, C1-6 alkyl or C1-6 alkenyl, and at least one R has formula (I), wherein n is an integer from seven to twenty and at least one of X or Y is -OH. The other of X or Y, which is not -OH, is hydrogen, CH3-, CH3-CH2-, CH3-(CH2)2- or (CH3)2-CH2-, and each W1, W2, and W3 is independently hydrogen, CH3-, CH3-CH2-, CH3-(CH2)2- or (CH3)2-CH2-. The X, Y, W1, W2, or W3 alkyl groups may be unsubstituted or substituted by an hydroxyl, halo or dimethylamino group. The disclosed compounds and therapeutic compositions thereof are useful in treating individuals having a disease or treatment-induced toxicity, mediated by second messenger activity. |
